表紙
市場調查報告書

泌尿科用設備的全球市場的預測:2019年∼2029年

Global Urology Devices Market Forecast 2019-2029: Urinary Incontinence, Benign Prostatic Hyperplasia, Kidney Stone, Prostate Cancer

出版商 Visiongain Ltd 商品編碼 430726
出版日期 內容資訊 英文 220 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
泌尿科用設備的全球市場的預測:2019年∼2029年 Global Urology Devices Market Forecast 2019-2029: Urinary Incontinence, Benign Prostatic Hyperplasia, Kidney Stone, Prostate Cancer
出版日期: 2019年05月21日內容資訊: 英文 220 Pages
簡介

泌尿科用設備市場在2018年達到69億美元,在2018年∼2029年間預測將以年複合成長率 (CAGR) 6.1%的速度成長。

本報告提供全球泌尿科用設備市場相關調查分析,市場概要,市場動態,市場預測,主要國家的預測,主要企業等相關的系統性資訊。

第1章 報告概要

第2章 泌尿科用設備市場簡介

  • 市場定義
  • 尿失禁
  • 前列腺肥大症 (BPH)
  • 腎結石
  • 前列腺癌症

第3章 泌尿科用設備市場預測

  • 市場成果
  • 市場預測

第4章 尿失禁用設備市場預測

  • 市場成果
  • 市場預測
    • 競爭市場
    • R&D活動的投資劇增
    • 美國的償付方案

第5章 BPH用設備市場預測

  • 市場成果
  • 市場預測
    • 發生率的增加
    • BPH設備的投資劇增

第6章 腎結石用設備市場預測

  • 市場成果
  • 市場預測
    • 盛行率的增加
    • 企業的舉措、投資的增加

第7章 前列腺癌症用設備市場預測

  • 市場成果
  • 市場預測
    • 高發生率
    • 技術的進步
    • 機器人的前列腺切除術

第8章 泌尿科用設備市場,各地區、各國:預測

  • 各地區的明細
    • 北美
    • 歐洲
    • 亞太地區
    • 中東、非洲
    • 其他

第9章 泌尿科用設備市場主要企業

  • 簡介
  • C.R. Bard (BD)
  • Coloplast
  • Endo Pharmaceuticals
  • Olympus
  • Teleflex Inc.
  • B. Braun
  • Boston Scientific Corporation
  • Cook Group
  • Healthtronics
  • Intuitive Surgical Inc.
  • Lumenis
  • Medtronic
  • Siemens Healthcare
  • Urologix
  • Urotech

第10章 泌尿科用設備市場SWOT分析

第11章 結論

附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: PHA0421

In 2018, the urology devices market is estimated at $6.9bn and is expected to grow at a CAGR of 6.1% from 2018 to 2029. The urinary incontinence market dominated the market in 2018 and accounted for 33.8% of the urology devices market.

How this report will benefit you

Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 220-page report you will receive 97 tables and 101 figures- all unavailable elsewhere.

The 220-page report provides clear detailed insight into the global urology devices market. Discover the key drivers and challenges affecting the market.

Report Scope

  • Revenue and growth forecasts from 2019 to 2029 for the global urology devices market
  • Revenue and growth forecasts from 2019 to 2029 for the global urology devices market by type:
  • Urinary Incontinence Devices
  • Benign Prostatic Hyperplasia (BPH) Devices
  • Prostate Cancer Devices
  • Kidney Stone Devices
  • Revenue and growth forecasts from 2019 to 2029 for the global urology devices market by regional and national market:
  • North America: the revenues are further broken down into the US, Canada, Rest of North America
  • Europe: the revenues are further broken down into the UK, Germany, France, Italy, Spain, Rest of Europe
  • Asia-Pacific: the revenues are further broken down into China, Japan, India, Australia, Rest of Asia-Pacific
  • Middle East and South Africa: the revenues are further broken down into GCC Countries, South Africa, Rest of Middle East and South Africa
  • Rest of the World

image1

  • Discussion and profiles of the leading players in the urology devices market:
  • C.R. Bard
  • Coloplast
  • Endo Pharmaceuticals
  • Olympus Corporation
  • Teleflex
  • Braun
  • Boston Scientific Corporation
  • Cook Group
  • Healthtronics
  • Intuitive Surgical Inc
  • Lumenis
  • Medtronic
  • Siemens Healthcare
  • Urologix
  • Urotech

The report provides financial information, key products as well as mergers & acquisitions activity.

  • A SWOT analysis of the global urology devices market, discussing the strengths, weaknesses, opportunities and threats in this market
  • Key Questions Answered by this Report:
  • How is the Urology Devices market evolving?
  • What is driving and restraining Urology Devices market dynamics?
  • How will each Urology Devices submarket segment grow over the forecast period and how much Sales will these submarkets account for in 2029?
  • How will market shares of each Urology Devices submarket develop from 2018-2029?
  • Which Urology Devices submarket will be the main driver of the overall market from 2018-2029?
  • How will market shares of the national markets change by 2029 and which nation will lead the market in 2029?
  • Who are the leading players?
  • How will the sector evolve as alliances form during the period between 2018 and 2029?

Visiongain's study is intended for anyone requiring commercial analyses for the global urology devices market. You find data, trends and predictions.

Table of Contents

1. Report Overview

  • 1.1 Global Urology Devices Market Overview
  • 1.2 Why You Should Read This Report
  • 1.3 How This Report Delivers
  • 1.4 Key Questions Answered by This Analytical Report
  • 1.5 Who is This Report For?
  • 1.6 Methodology
    • 1.6.1 Primary Research
    • 1.6.2 Secondary Research
    • 1.6.3 Market Evaluation & Forecasting Methodology
  • 1.7 Frequently Asked Questions (FAQ)
  • 1.8 Associated Visiongain Reports
  • 1.9 About Visiongain

2. Introduction to the Urology Devices Market

  • 2.1 Urology Devices Market Definition
  • 2.2 Urinary Incontinence
    • 2.2.1 Introduction
      • 2.2.2.1 Prevalence of Urinary Incontinence
    • 2.2.2 Diagnosis of Urinary Incontinence
    • 2.2.3 Treatment of Urinary Incontinence
      • 2.2.3.1 Artificial Urinary Sphincter
      • 2.2.3.2 Electric Stimulation
      • 2.2.3.3 Catheters
      • 2.2.3.4 Slings
  • 2.3 Benign Prostatic Hyperplasia (BPH)
    • 2.3.1 Introduction
    • 2.3.2 Diagnosis and Treatment
      • 2.3.2.1 Prostatic Stents
      • 2.3.2.2 Permanent Stents
        • 2.3.2.2.1 UroLume
        • 2.3.2.2.2 Memotherm
      • 2.3.2.3 Temporary Stents
        • 2.3.2.3.1 Urospiral and Prostakath
        • 2.3.2.3.2 Memokath
        • 2.3.2.3.3 ProstaCoil
        • 2.3.2.3.4 Polyurethane Stents
      • 2.3.2.4 Biodegradable stents
      • 2.3.2.5 Transurethral Needle Ablation Devices
      • 2.3.2.6 Transurethral Microwave Thermotherapy
      • 2.3.2.7 High-intensity Focused Ultrasound
      • 2.3.2.8 Laser surgery
      • 2.3.2.9 Other treatments
  • 2.4 Kidney Stones
    • 2.4.1 Introduction
    • 2.4.2 Causes and Diagnosis
    • 2.4.3 Types of Kidney stones
    • 2.4.4 Treatment Devices
      • 2.4.4.1 Extracorporeal Shockwave Lithotripsy (ESWL)
      • 2.4.4.2 Percutaneous Nephrolithotomy-lithotripsy (PCN)
      • 2.4.4.3 Ureteroscopy
  • 2.5 Prostate Cancer
    • 2.5.1 Introduction
    • 2.5.2 Prevalence
    • 2.5.3 Diagnosis of Prostate Cancer
      • 2.5.3.1 Prostate-Specific Antigen (PSA) Test
      • 2.5.3.2 Gleason Score
      • 2.5.3.3 Digital Rectal Exam (DRE)
    • 2.5.4 Treatment Methods-
      • 2.5.4.1 Radical Prostatectomy
      • 2.5.4.2 Radiation Therapy
        • 2.5.4.2.1 External Beam Radiation with X-rays and Proton Beams
        • 2.5.4.2.2 Brachytherapy
      • 2.5.4.3 Cryosurgery
      • 2.5.4.4 Other Treatments

3. Urology Devices Market Forecast 2019-2029

  • 3.1 Global Urology Devices Market, 2018
  • 3.2 Global Urology Devices Market Forecast, 2019-2029

4. Urinary Incontinence Devices Market Forecast 2019-2029

  • 4.1 Urinary Incontinence Devices Market, 2018
  • 4.2 Global Urinary Incontinence Devices Market Forecast, 2019-2029
  • 4.3 Global Urinary Incontinence Devices Market Forecast, 2019-2029
    • 4.3.1 Competitive Market
    • 4.3.2 Rising Investments for R&D Activities
    • 4.3.3 Reimbursement Scenario in the U.S.

5. Benign Prostatic Hyperplasia (BPH) Devices Market Forecast 2019-2029

  • 5.1 BPH Devices Market, 2018
  • 5.2 Global BPH Devices Market Forecast, 2019-2029
  • 5.3 Global BPH Devices Market, 2019-2029
    • 5.3.1 Increasing Incidence of BPH
    • 5.3.2 Rising Investments for BPH Devices

6. Kidney Stone Devices Market Forecast 2019-2029

  • 6.1 Kidney Stone Devices Market, 2018
  • 6.2 Global Kidney Stone Devices Market Forecast, 2019-2029
  • 6.3 Kidney Stone Devices Market Forecast, 2019-2029
    • 6.3.1 Increasing Prevalence of Kidney Stone Disease Will Drive the Market in the Coming Years
    • 6.3.2 Increasing Company Initiatives and Investments for Developing New Devices for Kidney Stones

7. Prostate Cancer Devices Market Forecast 2019-2029

  • 7.1 Prostate Cancer Devices Market, 2018
  • 7.2 Global Prostate Cancer Devices Market Forecast, 2019-2029
  • 7.3 Prostate Cancer Devices Market Forecast, 2019-2029
    • 7.3.1 High Incidence of Prostate Cancer
    • 7.3.2 Technological Advancements
    • 7.3.3 Robotic Prostatectomy Will Boost Growth Over the Forecast Period

8. Urology Devices Market by Regional and National Market: Forecast 2019-2029

  • 8.1 Regional Breakdown of the Urology Devices Market, 2018
    • 8.1.1 North America Urology Devices Market: Regional Forecast, 2019-2029
      • 8.1.1.1 USA Urology Devices Market Forecast, 2019-2029
      • 8.1.1.2 USA Urology Devices Market by Segment: Forecast 2019-2029
      • 8.1.1.3 Canada Urology Devices Market Forecast, 2019-2029
      • 8.1.1.4 Rest of North America Urology Devices Market: Regional Forecast, 2019-2029
    • 8.1.2 Europe Urology Devices Market: Regional Forecast, 2019-2029
      • 8.1.2.1 UK Urology Devices Market Forecast, 2019-2029
      • 8.1.2.2 Germany Urology Devices Market Forecast 2019-2029
      • 8.1.2.3 France Urology Devices Market Forecast 2018-2029
      • 8.1.2.4 Italy Urology Devices Market Forecast 2019-2029
      • 8.1.2.5 Spain Urology Devices Market Forecast 2019-2029
      • 8.1.2.6 Rest of Europe Urology Devices Market: Regional Forecast 2019-2029
    • 8.1.3 Asia-Pacific Urology Devices Market: Regional Forecast 2019-2029
      • 8.1.3.1 Japan Urology Devices Market Forecast 2019-2029
      • 8.1.3.2 China Urology Devices Market Forecast 2019-2029
      • 8.1.3.3 India Urology Devices Market Forecast 2019-2029
      • 8.1.3.4 Australia Urology Devices Market Forecast 2019-2029
      • 8.1.3.5 Rest of Asia-Pacific Urology Devices Market: Regional Forecast 2019-2029
    • 8.1.4 Middle East and South Africa Urology Devices Market Forecast 2019-2029
      • 8.1.4.1 GCC Countries Urology Devices Market 2018-2029
      • 8.1.4.2 South Africa Urology Devices Market Forecast 2019-2029
      • 8.1.4.3 Rest of Middle East and South Africa Urology Devices Market Forecast 2019-2029
    • 8.1.5 Rest of the World (ROW) Urology Devices Market Forecast 2019-2029

9. Leading Urology Devices Companies

  • 9.1 Introduction
  • 9.2 C.R. Bard (BD)
    • 9.2.1 Introduction
    • 9.2.2 Recent Performance Analysis
    • 9.2.3 Total Company Sales by Business Segments, 2017
    • 9.2.4 Market Share by Business Segments, 2017
    • 9.2.5 Changes in Business Segments, 2016-2017
    • 9.2.6 Sales by Regional Segments, 2017
    • 9.2.7 Market Share by Regional Segments, 2017
    • 9.2.8 C.R. Bard Urology Products
    • 9.2.9 Mergers & Acquisitions (M&A) Activity
  • 9.3 Coloplast
    • 9.3.1 Introduction
    • 9.3.2 Recent Performance Analysis
    • 9.3.3 Total Company Sales by Business Segments, 2017
    • 9.3.4 Market Share by Business Segments, 2017
    • 9.3.5 Changes in Business Segments, 2016-2017
    • 9.3.6 Sales by Regional Segments,2017
    • 9.3.7 Market Share by Regional Segments, 2017
    • 9.3.8 Coloplast Urology Products
    • 9.3.9 Mergers & Acquisitions (M&A) Activity
  • 9.4 Endo Pharmaceuticals
    • 9.4.1 Introduction
    • 9.4.2 Recent Performance Analysis
    • 9.4.3 Total Company Sales by Business Segments, 2017
    • 9.4.4 Market Share by Business Segments, 2017
    • 9.4.5 Changes in Business Segments, 2016-2017
    • 9.4.6 Endo Pharmaceuticals Urology Products
    • 9.4.7 Mergers & Acquisitions (M&A) Activity
  • 9.5 Olympus Corporation
    • 9.5.1 Introduction
    • 9.5.2 Recent Performance Analysis
    • 9.5.3 Total Company Sales by Business Segments,2017
    • 9.5.4 Market Share by Business Segments, 2017
    • 9.5.5 Sales by Regional Segments, 2017
    • 9.5.6 Market Share by Regional Segments, 2017
    • 9.5.7 Olympus Corporation Urology Products
    • 9.5.8 Strategies
  • 9.6 Teleflex Inc.
    • 9.6.1 Introduction
    • 9.6.2 Recent Performance Analysis
    • 9.6.3 Total Company Sales by Business Segments,2017
    • 9.6.4 Market Share by Business Segments,2017
    • 9.6.5 Changes in Business Segments, 2016-2017
    • 9.6.6 Teleflex Urology Products
    • 9.6.7 Mergers & Acquisitions (M&A) Activity
  • 9.7 B. Braun
    • 9.7.1 Introduction
    • 9.7.2 Recent Performance Analysis
    • 9.7.3 Total Company Sales by Business Segments, 2017
    • 9.7.4 Market Share by Business Segments, 2017
    • 9.7.5 Changes in Business Segments, 2016-2017
    • 9.7.6 Sales by Regional Segments,2017
    • 9.7.7 Market Share by Regional Segments, 2017
    • 9.7.8 B. Braun Urology Products
  • 9.8 Boston Scientific Corporation
    • 9.8.1 Introduction
    • 9.8.2 Recent Performance Analysis
    • 9.8.3 Total Company Sales by Business Segments,2017
    • 9.8.4 Market Share by Business Segments, 2017
    • 9.8.5 Changes in Business Segments, 2016-2017
    • 9.8.6 Sales by Regional Segments, 2017
    • 9.8.7 Market Share by Regional Segments,2017
    • 9.8.8 Boston Scientific Urology Products
    • 9.8.9 Mergers & Acquisitions (M&A) Activity
  • 9.9 Cook Group
    • 9.9.1 Introduction
    • 9.9.2 Cook Medical Urology Products
    • 9.9.3 Developments
  • 9.10 Healthtronics
    • 9.10.1 Introduction
    • 9.10.2 Healthtronics Urology Products
    • 9.10.3 Recent Activity
  • 9.11 Intuitive Surgical Inc.
    • 9.11.1 Introduction
    • 9.11.2 Recent Performance Analysis
    • 9.11.3 Total Company Sales by Business Segments, 2017
    • 9.11.4 Market Share by Business Segments, 2017
    • 9.11.5 Change in Business Segments, 2016-2017
    • 9.11.6 Sales by Regional Segments,2017
    • 9.11.7 Market Share by Regional Business Segments, 2017
    • 9.11.8 Intuitive Surgical Inc. Urology Products
    • 9.11.9 Recent Activities
  • 9.12 Lumenis
    • 9.12.1 Introduction
    • 9.12.2 Lumenis Urology Products
    • 9.12.13 Recent Activities
  • 9.13 Medtronic
    • 9.13.1 Introduction
    • 9.13.2 Recent Performance Analysis
    • 9.13.3 Total Company Sales by Business Segments, 2017
    • 9.13.4 Market Share by Business Segments, 2017
    • 9.13.5 Sales by Regional Segments,2017
    • 9.13.6 Market Share by Regional Business Segments, 2017
    • 9.13.7 Medtronic Urology Products
    • 9.13.8 Recent Activities
  • 9.14 Siemens Healthcare
    • 9.14.1 Introduction
    • 9.14.2 Recent Performance Analysis
    • 9.14.3 Total Company Sales by Business Segments, 2017
    • 9.14.4 Market Share by Business Segments, 2017
    • 9.14.5 Changes in Business Segments, 2016-2017
    • 9.14.6 Sales by Regional Segments,2017
    • 9.14.7 Market Share by Regional Business Segments, 2017
    • 9.14.8 Siemens Healthcare Urology Products
  • 9.15 Urologix
    • 9.15.1 Introduction
    • 9.15.2 Urologix Urology Products
    • 9.15.3 Recent Activities
  • 9.16 Urotech
    • 9.16.1 Introduction
    • 9.16.2 Urotech Urology Products

10. SWOT Analysis of the Urology Devices Market 2018-2029

  • 10.1 Strengths
    • 10.1.1 Aging Population
    • 10.1.2 Rising Incidence of Obesity
    • 10.1.3 Increasing Demand for Minimally Invasive Procedures
    • 10.1.4 Growing Awareness
    • 10.1.5 Technological Advancements
  • 10.2 Weaknesses
    • 10.2.1 High Cost of Devices
    • 10.2.2 Social Stigma Associated with Urologic Conditions
    • 10.2.3 Disadvantages of Urological Devices
  • 10.3 Opportunities
    • 10.3.1 Healthcare Expenditures
    • 10.3.2 Automated Urological Products
  • 10.4 Threats
    • 10.4.1 Alternative Medication Therapies
    • 10.4.2 High Cost of R&D Activities

11. Conclusion

  • 11.1 Urology Devices Market Forecast
  • 11.2 The U.S. Holds the Largest Market Share
  • 11.3 Urinary Incontinence Dominates the Urology Devices Market

Appendices

  • Associated Visiongain Reports
  • Visiongain Report Sales Order Form
  • About Visiongain
  • Visiongain Report Evaluation Form

List of Tables

  • Table 2.1 Global Prevalence of Urinary Incontinence as percentage of total population
  • Table 2.2 Prevalence percentage of the different types of UI among the global population
  • Table 3.1 Global Urology Devices Market: Revenue ($m) and Market Share (%) by Segment, 2018
  • Table 3.2 Global Urology Devices Market Forecast: Revenues ($m), AGR (%),
  • CAGR (%), 2019-2029
  • Table 4.1 Global Urinary Incontinence Devices Market: Revenue ($m) and Market Share (%) by Subsegment, 2018
  • Table 4.2 Global Urinary Incontinence Devices Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2019-2029
  • Table 5.1 Global BPH Devices Market: Revenue ($m) and Market Share (%) by Subsegment, 2018
  • Table 5.2 Global BPH Devices Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2019-2029
  • Table 6.1 Global Kidney Stone Market: Revenue ($m) and Market Share (%) by Subsegment, 2018
  • Table 6.2 Global Kidney Stone Devices Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2019-2029
  • Table 7.1 Global Prostate Cancer Devices Market: Revenue ($m) and Market Share (%) by Subsegment, 2018
  • Table 7.2 Global Prostate Cancer Devices Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2019-2029
  • Table 8.1 Urology Devices Market Forecast by Region: (% Share), 2019-2029
  • Table 8.2 Urology Devices Market Forecast by Region: Revenues ($m), 2019-2029
  • Table 8.3 North America Urology Devices Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2019-2029
  • Table 8.4 USA Urology Devices Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2019-2029
  • Table 8.5. USA Urology Devices Market Forecast by Segment: (% Share), 2019-2029
  • Table 8.6 USA Urology Devices Market Forecast by Segment: Revenues ($m), AGR (%), 2019-2029
  • Table 8.7 Canada Urology Devices Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2019-2029
  • Table 8.8 Canada Urology Devices Market Forecast by Segment: (% Share), 2019-2029
  • Table 8.9 Canada Urology Devices Market Forecast by Segment: Revenues ($m), AGR (%), 2019-2029
  • Table 8.10 Rest of North America Urology Devices Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2019-2029
  • Table 8.11 Europe Urology Devices Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2019-2029
  • Table 8.12 Europe Urological Devices Market Forecast by Country: (% Share), 2019-2029
  • Table 8.13. Europe Urology Devices Market Forecast: Revenues ($m), AGR (%), 2019-2029
  • Table 8.14. UK Urology Devices Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2019-2029
  • Table 8.15 UK Urology Devices Market by Segment: Revenues ($m), AGR (%), 2019-2029
  • Table 8.16 Germany Urology Devices Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2019-2029
  • Table 8.17. Germany Urology Devices Market Forecast by Segment: Revenues ($m), AGR (%), 2019-2029
  • Table 8.17 France Urology Devices Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2019-2029
  • Table. 8.18. France Urology Devices Market by Segment: Revenues ($m), AGR (%), 2019-2029
  • Table 8.19 Italy Urology Devices Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2019-2029
  • Table 8.20 Italy Urology Devices Market by Segment: Revenues ($m), AGR (%), 2019-2029
  • Table 8.21 Spain Urology Devices Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2019-2029
  • Table 8.22 Spain Urology Devices Market by Segment: Revenues ($m), AGR (%), 2019-2029
  • Table 8.23 Rest of Europe Urology Devices Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2019-2029
  • Table 8.24 Rest of Europe Urology Devices Market Forecast by Segment: Revenues ($m), AGR (%), 2019-2029
  • Table 8.25 Asia-Pacific Urology Devices Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2019-2029
  • Table 8.26 Asia-Pacific Urology Devices Market by Segment: Revenues ($m), AGR (%), 2019-2029
  • Table 8.27 Japan Urology Devices Market: Revenue ($m), AGR (%), CAGR (%), 2019-2029
  • Table 8.28 Japan Urology Devices Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2019-2029
  • Table 8.29 China Urology Devices Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2019-2029
  • Table 8.30 China Urology Devices Market Forecast by Segment: Revenues ($m), AGR (%), 2019-2029
  • Table 8.31 India Urology Devices Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2019-2029
  • Table 8.32 India Urology Devices Market by Segment: Revenues ($m), AGR (%), 2019-2029
  • Table 8.33 Australia Urology Devices Market: Revenues ($m), AGR (%), CAGR (%), 2019-2029
  • Table 8.34 Australia Urology Devices Market Forecast by Segment: Revenues ($m), AGR (%), 2019-2029
  • Table 8.35 Rest of Asia-Pacific Urology Devices Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2019-2029
  • Table 8.36 Rest of Asia-Pacific Urology Market Forecast by Segment: Revenues ($m), AGR (%), 2019-2029
  • Table 8.37 Middle East and South Africa Urology Devices Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2019-2029
  • Table 8.38 Middle East and South Africa Urology Devices Market: Revenues ($m), AGR (%), 2019-2029
  • Table 8.39 GCC Urology Devices Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2019-2029
  • Table 8.40 GCC Countries Urology Devices Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2019-2029
  • Table 8.41 South Africa Urology Devices Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2019-2029
  • Table 8.42 South Africa Urology Devices Market Forecast: Revenues ($m), AGR (%), 2019-2029
  • Table 8.43 Rest of Middle East and South Africa Urological Devices Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2019-2029
  • Table 8.44 Rest of Middle East and South Africa Market Forecast: Revenues ($m), AGR (%), 2019-2029
  • Table 8.45 ROW Urology Devices Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2019-2029
  • Table 9.1 C.R. Bard: Sales ($m) and Market Shares (%) by Business Segments, 2017
  • Table 9.2 C.R. Bard: Sales ($m) and Market Shares (%) by Regions, 2017
  • Table 9.3 C.R. Bard Urology Products
  • Table 9.4 Coloplast: Sales ($m) and Market Shares (%) by Business Segments, 2017
  • Table 9.5 Coloplast: Sales ($m) and Market Shares (%) by Regions, 2017
  • Table 9.6 Coloplast Urology Products
  • Table 9.7 Endo Pharmaceuticals: Sales ($m) and Market Shares (%) by Business Segments, 2017
  • Table 9.8 Endo Pharmaceuticals Urology Products
  • Table 9.9 Olympus Corporation: Sales (JPY Billion) and Market Shares (%) by Business Segments, 2017
  • Table 9.10 Olympus Corporation: Sales (JPY billion) and Market Shares (%) by Regions, 2017
  • Table 9.11 Olympus Corporation Urology Products
  • Table 9.12 Teleflex: Sales ($m) and Market Shares (%) by Business Segments, 2017
  • Table 9.13 Coloplast Urology Products
  • Table 9.14 B. Braun: Sales (€Million) and Market Shares (%) by Business Segments, 2017
  • Table 9.15 B. Braun: Sales (€Million) and Market Shares (%) by Regions, 2017
  • Table 9.16 B. Braun Urology Products
  • Table 9.17 Boston Scientific: Sales ($m) and Market Shares (%) by Business Segments, 2017
  • Table 9.18 Boston Scientific: Sales ($m) and Market Shares (%) by Region, 2017
  • Table 9.19 Boston Scientific Urology Products
  • Table 9.20 Cook Medical Urology Products
  • Table 9.21 Healthtronics Urology Products
  • Table 9.22 Intuitive Surgical Inc.: Sales ($m) and Market Shares (%) by Business Segments, 2017
  • Table 9.23 Intuitive Surgical Inc.: Sales ($m) and Market Shares (%) by Region, 2017
  • Table 9.24 Intuitive Surgical Inc. Urology Products
  • Table 9.25 Lumenis Urology Products
  • Table 9.26 Medtronic: Sales ($bn) and Market Shares ($m) by Business Segments, 2017
  • Table 9.27 Medtronic: Sales ($bn) and Market Shares (%) by Regions, 2017
  • Table 9.28 Medtronic Urology Products
  • Table 9.29 Siemens Healthcare: Sales (€Million) and Market Shares (%) by Business Segments, 2017
  • Table 9.30 Siemens Healthcare: Sales (€Million) and Market Shares (%) by Region, 2017
  • Table 9.31 Siemens Healthcare Urology Products
  • Table 9.32 Urologix Urology Products
  • Table 9.33 Urotech Urology Products
  • Table 10.1 Global Urology Devices Market SWOT Analysis
  • Table 10.2 Healthcare Expenditure (% of GDP)
  • Table 11.1 Global Urology Devices Market Forecast: Revenue ($m), AGR (%), CAGR (%), 2018, 2023, 2029
  • Table 11.2 Global Urology Devices Market Forecast by Region: Revenues ($m), 2019-2029

List of Figures

  • Figure 2.1 Global prevalence of Urinary Incontinence Among Males (in %)
  • Figure 2.2 Global prevalence of Urinary Incontinence Among Females (in %)
  • Figure 3.1 Global Urology Devices Market: Revenue ($m) by Segment, 2018
  • Figure 3.2 Global Urology Device: Market Share (%) by Segment, 2018
  • Figure 4.1 Global Urinary Incontinence Devices Market: Revenue ($m) by Subsegment, 2018
  • Figure 4.2 Global Urinary Incontinence Devices Market: Market Share (%) by Subsegment, 2018
  • Figure 4.3 Global Urinary Incontinence Devices Market Forecast: Revenue ($m), AGR (%), 2019-2029
  • Figure 5.1 Global BPH Devices Market: Revenue ($m) by Subsegment, 2018
  • Figure 5.2 Global BPH Devices Market: Market Share (%) by Subsegment, 2018
  • Figure 5.3 Global BPH Devices Market Forecast: Revenue ($m), AGR (%), 2019-2029
  • Figure 6.1 Global Kidney Stone Devices Market: Revenue ($m) by Subsegment, 2018
  • Figure 6.2 Global Kidney Stone Devices Market: Market Share (%) by Subsegment, 2018
  • Figure 6.3 Global Kidney Stone Devices Market Forecast: Revenue ($m), AGR (%), 2019-2029
  • Figure 7.1 Global Prostate Cancer Devices Market: Revenue ($m) by Sub-segment, 2018
  • Figure 7.2 Global Prostate Cancer Devices Market: Market Share (%) by Subsegment, 2018
  • Figure 7.3 Global Prostate Cancer Devices Market Forecast: Revenues ($m), AGR (%), 2019-2029
  • Figure 8.1 Urology Devices Market Forecast by Region: (% Share), 2019-2029
  • Figure 8.2 Urology Devices Market by Region: (% Share), 2018
  • Figure 8.3 North America Urology Devices Market Forecast: Revenues ($m), AGR (%), 2019-2029
  • Figure 8.4 North America Urology Devices Market by Country: (% Share), 2018
  • Figure 8.5 USA Urology Devices Market Forecast: Revenues ($m), AGR (%), 2019-2029
  • Figure 8.6 USA Urology Devices Market Forecast by Segment: (% Share), 2019-2029
  • Figure 8.7 Canada Urology Devices Market Forecast: Revenues ($m), AGR (%), 2019-2029
  • Figure 8.8 Canada Urology Device Market by Segment: (% Share), 2018
  • Figure 8.9 Rest of North America Urology Devices Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2019-2029
  • Figure 8.10 Europe Urology Devices Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2019-2029
  • Figure 8.11 Europe Urological Devices Market by Country: (% Share), 2018
  • Figure 8.12 Europe Urology Devices Market by Segment: Share (%), 2018
  • Figure 8.13 UK Urology Devices Market Forecast: Revenues ($m), AGR (%), 2019-2029
  • Figure 8.14 UK Urology Devices Market by Segment: Revenues ($m), 2018
  • Figure. 8.15 Germany Urology Devices Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2019-2029
  • Figure 8.16 Germany Urology Devices Market by Segment: Revenues ($m), 2018
  • Figure 8.17 France Urology Devices Market Forecast: Revenues ($m), AGR (%), 2019-2029
  • Figure 8.18 France Urology Devices Market by Segment: Revenues ($m), 2018
  • Figure 8.19 Italy Urology Devices Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2019-2029
  • Figure 8.20 Italy Urology Devices Market by Segment: Revenues ($m), 2018
  • Figure 8.21 Spain Urology Devices Market Forecast: Revenues ($m), AGR (%), 2019-2029
  • Figure 8.22 Spain Urology Devices Market: Revenues ($m), 2018
  • Figure 8.23 Rest of Europe Urology Devices Market: Revenues ($m), AGR (%), 2019-2029
  • Figure 8.24 Rest of Europe Urology Devices Market: Revenues ($m), 2018
  • Figure 8.25 Asia-Pacific Urology Devices Market Forecast: Revenues ($m), AGR (%), 2019-2029
  • Figure 8.26 Asia-Pacific Urology Devices: Market Share (%), 2018
  • Figure 8.27 Asia-Pacific Urology Devices Market Forecast: Revenues ($m), 2018
  • Figure 8.28 Japan Urology Devices Market Forecast: Revenues ($m), AGR (%), 2019-2029
  • Figure 8.29 Japan Urology Devices Market: Revenues ($m), 2018
  • Figure 8.30 China Urology Devices Market Forecast: Revenues ($m), AGR (%), 2019-2029
  • Figure 8.31 China Urology Devices Market: Revenues ($m), 2018
  • Figure 8.32 India Urology Devices Market Forecast: Revenues ($m), AGR (%), 2019-2029
  • Figure 8.33 India Urology Devices Market: Revenues ($m), 2018
  • Figure 8.34 Australia Urology Devices Market Forecast: Revenues ($m), AGR (%), 2019-2029
  • Figure 8.35 Australia Urology Devices Market by Segment: Revenues ($m), 2018
  • Figure 8.36 Rest of Asia-Pacific Urology Devices Market: Revenues ($m), AGR (%), 2019-2029
  • Figure 8.37 Rest of Asia-Pacific Urology Devices Market: Revenues ($m), 2018
  • Figure 8.38 Middle East and South Africa Urology Devices Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2019-2029
  • Figure 8.39 The Middle East and South Africa Urology Devices Market: (% Share), 2018
  • Figure 8.40 Middle East and South Africa Urology Devices Market: Revenues ($m), 2018
  • Figure 8.41 GCC Countries Urology Devices Market Forecast: Revenues ($m), AGR (%), 2019-2029
  • Figure 8.42 GCC Urological Devices Market by Segment: Revenues ($m), 2018
  • Figure 8.43 South Africa Urology Devices Market Forecast: Revenues ($m), AGR (%), 2019-2029
  • Figure 8.44 South Africa Urology Devices Market: Revenues ($m), 2018
  • Figure 8.45 Rest of Middle East and South Africa Urological Devices Market Forecast: Revenues ($m), AGR (%), 2019-2029
  • Figure 8.46 Rest of Middle East and South Africa Urology Devices Market: Revenues ($m), 2018
  • Figure 8.47 ROW Urology Devices Market Forecast: Revenues ($m), AGR (%), 2019-2029
  • Figure 9.1 C.R. Bard: Sales ($m) by Business Segments, 2017
  • Figure 9.2 C.R. Bard: Market Shares (%) by Business Segments, 2017
  • Figure 9.3 Change in Sales ($m) by Business Segment, 2016-2017
  • Figure 9.4 C.R. Bard: Market Shares (%) by Region, 2017
  • Figure 9.5 Coloplast: Sales ($m) by Business Segments, 2017
  • Figure 9.6 Coloplast: Market Shares (%) by Business Segments, 2017
  • Figure 9.7 Change in Sales ($m) by Business Segment, 2016-2017
  • Figure 9.8 Coloplast: Market Shares (%) by Region, 2017
  • Figure 9.9 Endo Pharmaceuticals: Sales ($m) by Business Segments, 2017
  • Figure 9.10 Endo Pharmaceuticals: Market Shares (%) by Business Segments, 2017
  • Figure 9.11 Change in Sales ($m) by Business Segment, 2016-2017
  • Figure 9.12 Olympus Corporation: Sales (JPY billion) by Business Segments, 2017
  • Figure 9.13 Olympus Corporation: Market Shares (%) by Business Segments, 2017
  • Figure 9.14 Olympus Corporation: Market Shares (%) by Region, 2017
  • Figure 9.15 Teleflex: Sales ($m) by Business Segments, 2017
  • Figure 9.16 Teleflex: Market Shares by Business Segments, 2017
  • Figure 9.17 Change in Sales ($m) by Business Segment, 2016-2017
  • Figure 9.18 B. Braun: Sales (€Million) by Business Segments, 2017
  • Figure 9.19 B. Braun: Market Shares (%) by Business Segments, 2017
  • Figure 9.20 Change in Sales (€Million) by Business Segment, 2016-2017
  • Figure 9.21 B. Braun: Market Shares (%) by Region, 2017
  • Figure 9.22 Boston Scientific: Sales ($m) by Business Segments, 2017
  • Figure 9.23 Boston Scientific: Market Shares (%) by Business Segments, 2017
  • Figure 9.24 Change in Sales ($m) by Business Segment, 2016-2017
  • Figure 9.25 Boston Scientific: Market Shares (%) by Region, 2017
  • Figure 9.26 Intuitive Surgical Inc.: Sales ($m) by Business Segments, 2017
  • Figure 9.27 Intuitive Surgical Inc.: Market Shares (%) by Business Segments, 2017
  • Figure 9.28 Change in Sales ($m) by Business Segment, 2016-2017
  • Figure 9.29 Intuitive Surgical Inc.: Market Shares (%) by Region, 2017
  • Figure 9.30 Medtronic: Sales ($bn) by Business Segments, 2017
  • Figure 9.31 Medtronic: Market Shares (%) by Business Segments, 2017
  • Figure 9.32 Medtronic: Market Shares (%) by Region, 2017
  • Figure 9.33 Siemens Healthcare: Sales (€million) by Business Segments, 2017
  • Figure 9.34 Siemens Healthcare: Market Shares (%) by Business Segments, 2017
  • Figure 9.35 Change in Sales (€Million) by Business Segment, 2016-2017
  • Figure 9.36 Siemens Healthcare: Market Shares (%) by Region, 2017
  • Figure 10.1 Rising Aging Population (over 60 years of age), in Billions
  • Figure 11.1 Global Urology Devices Market by Region: (% Share), 2018

Companies Listed

  • Adapta Medical, Inc.
  • Advanced Urotech.
  • American Medical Systems (AMS)
  • Angiomed
  • Aspen Holdings
  • B. Braun
  • Bard
  • BDC Venture Capital
  • Boston Scientific Corporation
  • C.R. Bard
  • Carolina Lithotripsy
  • Coloplast
  • Coloplast (China) Ltd.
  • Coloplast Canada Corporation
  • Coloplast Corp
  • Coloplast de Argentina S.A.
  • Coloplast GmbH
  • Coloplast Korea Limited
  • Cook Group
  • Cook Medical
  • Distal Access, LLC.
  • EastMed Inc.
  • Endo Pharmaceuticals
  • Endo Pharmaceuticals Holding, Inc.
  • Engineers & Doctors
  • Gran Plasa
  • GT Urological LLC
  • Healthtronics
  • Hill-Rom Holdings, Inc.
  • Innovacorp
  • Instent
  • Intuitive Surgical Inc.
  • Karl Storz
  • Kimberly Clark
  • Kobayashi Pharmaceutical Co., Ltd.
  • Liberator Medical Holdings, Inc.
  • Litha
  • Lumenis
  • Medicon, Inc.
  • Medi-Tate Ltd
  • Medtronic
  • Mobile Medical Marketing, LLC.
  • MyoPowers
  • Nostix, LLC
  • Novartis
  • Novation
  • Olympus Corporation
  • Paladin Labs
  • Par Pharmaceutical
  • Par Pharmaceutical Holdings, Inc.
  • Porges
  • Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
  • Siemens Healthcare
  • SOMAR
  • SonoMotion
  • Teleflex Inc.
  • Terumo Corporation
  • TransEnterix, Inc.
  • Truffle Capital
  • Trumpf Medical
  • United Therapies, LLC.

List of Organizations Mentioned in the Report

  • American Cancer Society
  • Federal Food, Drug, and Cosmetic Act (FFDCA)
  • Food and Drug Administration (FDA)
  • Health Canada
  • Medicare
  • National Institute for Health and Care Excellence (NICE)
  • National Institutes of Health (NIH)
  • Pharmaceuticals Medical Devices Agency (PMDA)
  • World Bank
  • World Cancer Research Fund International
  • World Health Organization (WHO)
Back to Top